Clinical Trial Update: Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a radiation- and alkylator-free bone marrow transplantation regimen for patients with Dyskeratosis Congenita and relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Dyskeratosis Congenita
• Hoyeraal-hreidarsson Syndrome
• Revesz Syndrome

Snippet

Sponsor: Boston Children's Hospital | Conditions: Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING